Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: Relevance for human exposures

Frederick S vom Saal; Catherine A VandeVoort; Julia A Taylor; Wade V Welshons; Pierre-Louis Toutain; Patricia A Hunt

doi:10.1016/j.reprotox.2014.01.007

Back

Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: Relevance for human exposures

Journal article

Open access

Peer reviewed

Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: Relevance for human exposures

Frederick S vom Saal, Catherine A VandeVoort, Julia A Taylor, Wade V Welshons, Pierre-Louis Toutain and Patricia A Hunt

Reproductive toxicology (Elmsford, N.Y.), Vol.45, pp.105-116

06/2014

DOI: https://doi.org/10.1016/j.reprotox.2014.01.007

Handle:

https://hdl.handle.net/2376/110585

PMCID: PMC4035044

PMID: 24582107

Files and links (1)

url

https://doi.org/10.1016/j.reprotox.2014.01.007View

Published (Version of record) Open

Abstract

Pregnancy

Bisphenol A

Maternal

Rhesus monkey

Fetus

Pharmacokinetics

•dBPA pharmacokinetics differed in non-pregnant and pregnant female monkeys.•Serum conjugated/unconjugated dBPA was higher feeding dBPA than with sc capsules.•Mothers with highest unconjugated serum dBPA had lowest conjugated/unconjugated ratio.•Capsules led to higher unconjugated and lower conjugated dBPA in mothers than fetuses.•Oral dBPA led to adverse effects in fetal lungs, brain, mammary glands and ovaries. We measured serum dBPA in non-pregnant and pregnant female rhesus monkeys, fetuses and amniotic fluid. dBPA was administered by a daily oral bolus or sc implantation of Silastic capsules; both resulted in daily average serum unconjugated dBPA concentrations of <1ng/ml. We observed lower serum concentrations of unconjugated dBPA in pregnant females relative to pre-pregnancy values, and generally lower concentrations in fetal serum than in maternal serum. Differences in pharmacokinetics of dBPA were evident between pre-pregnancy, early and late pregnancy, likely reflecting changes in maternal, fetal and placental physiology. The serum ratio of conjugated to unconjugated dBPA after continuous sc release of dBPA was similar to values reported in human biomonitoring studies and markedly lower than with oral administration, suggesting oral bolus exposure is not an appropriate human exposure model. We report elsewhere that there were numerous adverse effects on fetuses exposed to very low serum dBPA in these studies.

Metrics

7 Record Views

See more details

Details

Title: Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: Relevance for human exposures
Creators: Frederick S vom Saal - Division of Biological Sciences, University of Missouri, Columbia, MO, United States
Catherine A VandeVoort - Department of Obstetrics and Gynecology, University of California, Davis, CA, United States
Julia A Taylor - Division of Biological Sciences, University of Missouri, Columbia, MO, United States
Wade V Welshons - Department of Biomedical Sciences, University of Missouri, Columbia, MO, United States
Pierre-Louis Toutain - Université de Toulouse, INPT, ENVT, UPS, UMR1331, F- 31062 Toulouse, France
Patricia A Hunt - School of Molecular Biosciences, Washington State University, Pullman, WA, United States
Publication Details: Reproductive toxicology (Elmsford, N.Y.), Vol.45, pp.105-116
Academic Unit: Molecular Biosciences, School of
Publisher: Elsevier Inc
Identifiers: 99900547047501842
Language: English
Resource Type: Journal article